Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/NBE-Therapeutics

NBE-Therapeutics

Series B
Basel, SwitzerlandFounded 2012Nov 2016
Healthtech

NBE-Therapeutics raised €19M in a Series B round in Nov 2016. The company is based in Basel, Switzerland. Investors in the round: Boehringer Ingelheim Venture Fund, PPF Group. Data as of Nov 2026.

← NBE-Therapeutics
Amount raised
€19M
€18,700,000
Native amount
18,700,000 EUR
Stage
Series B
series b
Investors
2

Provenance & confidence

Unverified
Amount

Reported in EUR — no conversion. €19M

High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

2 named
Boehringer Ingelheim Venture FundPPF Group
Date
Nov 2016
Round type
series b
Amount (EUR)
€19M

Other rounds

same company